Christopher L Corless Selected Research

Christopher L Corless Research Topics

Disease

81	Neoplasms (Cancer) 04/2024 - 03/2002
41	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 03/2002
12	Breast Neoplasms (Breast Cancer) 10/2021 - 06/2005
11	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2005
9	Adenocarcinoma 12/2018 - 12/2004
8	Carcinoma (Carcinomatosis) 01/2016 - 07/2005
8	Melanoma (Melanoma, Malignant) 05/2015 - 09/2003
7	Sarcoma (Soft Tissue Sarcoma) 01/2023 - 01/2004
7	Disease Progression 10/2022 - 02/2005
6	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 12/2004
5	Carcinogenesis 01/2022 - 07/2003
4	Aggressive Fibromatosis (Desmoid) 08/2022 - 06/2005
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2018 - 03/2002
3	Ductal Carcinoma 07/2013 - 01/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2013 - 08/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2010 - 05/2002
3	Systemic Mastocytosis 05/2009 - 11/2006
3	Leukemia 05/2009 - 12/2003
2	Fibroma (Fibromatosis) 08/2022 - 06/2005
2	Rhabdomyosarcoma 01/2022 - 01/2013
2	Cholangiocarcinoma 08/2015 - 10/2012
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 09/2014 - 01/2014
2	Pathologic Complete Response 12/2011 - 05/2007
2	Fibrosis (Cirrhosis) 11/2011 - 03/2007
2	Liver Diseases (Liver Disease) 09/2010 - 04/2003
2	Papilloma (Papillomatosis) 01/2010 - 07/2005
2	Dermatofibrosarcoma 05/2008 - 02/2005
2	Mastocytosis 11/2006 - 03/2002
2	Squamous Cell Carcinoma of Head and Neck 05/2006 - 07/2004
2	Seminoma 01/2004 - 03/2002
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2003 - 03/2002
1	Triple Negative Breast Neoplasms 10/2021
1	Bites and Stings (Sting) 10/2021
1	Glioma (Gliomas) 10/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020
1	Epilepsy (Aura) 10/2019

Drug/Important Bio-Agent (IBA)

42	Imatinib Mesylate (Gleevec)FDA Link 11/2023 - 03/2002
28	Phosphotransferases (Kinase)IBA 11/2023 - 03/2002
10	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 11/2023 - 12/2003
10	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 07/2004
10	Proteins (Proteins, Gene)FDA Link 10/2021 - 09/2003
9	Tyrosine Kinase InhibitorsIBA 01/2022 - 03/2002
9	ParaffinIBA 11/2016 - 07/2004
8	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019 - 05/2002
7	Monoclonal AntibodiesIBA 01/2013 - 07/2003
4	tyrosine receptor (receptor, tyrosine)IBA 01/2021 - 01/2007
4	Formaldehyde (Formol)FDA Link 11/2016 - 04/2010
4	Biomarkers (Surrogate Marker)IBA 03/2015 - 05/2006
4	Sunitinib (Sutent)FDA Link 07/2012 - 01/2008
3	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 01/2014
3	Codon (Codons)IBA 11/2017 - 07/2004
3	Tyrosine (L-Tyrosine)FDA Link 09/2014 - 05/2008
3	Cadherins (E-Cadherin)IBA 12/2012 - 07/2005
3	AntibodiesIBA 03/2009 - 07/2003
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2005 - 03/2002
2	Protein Isoforms (Isoforms)IBA 11/2023 - 12/2003
2	beta CateninIBA 08/2022 - 03/2006
2	CollagenIBA 01/2021 - 02/2005
2	Dasatinib (BMS 354825)FDA Link 01/2016 - 05/2009
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 06/2005
2	Gemcitabine FDA Link 08/2015 - 08/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2015 - 07/2013
2	ChromatinIBA 02/2014 - 10/2011
2	DesminIBA 01/2014 - 04/2011
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 03/2009
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 04/2010 - 01/2004
2	Oncogene Proteins (Oncogene Protein)IBA 12/2008 - 01/2003
2	Transforming Growth Factor-beta Type II ReceptorIBA 05/2006 - 07/2005
2	Complementary DNA (cDNA)IBA 08/2005 - 07/2004
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 07/2005 - 07/2004
1	Immune Checkpoint InhibitorsIBA 04/2024
1	tovorafenibIBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2022
1	O-methyl-serine dodecylamide hydrochlorideIBA 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021
1	entrectinibIBA 10/2021
1	selitrectinibIBA 10/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Calcibiotic Root Canal SealerIBA 01/2020
1	Circulating Tumor DNAIBA 01/2019
1	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2016

Therapy/Procedure

42	Therapeutics 10/2022 - 03/2002
8	Drug Therapy (Chemotherapy) 10/2019 - 01/2005
4	Neoadjuvant Therapy 01/2022 - 05/2007
4	Radiotherapy 08/2015 - 07/2006
3	Semiconductors 11/2016 - 03/2013
3	Transplantation 09/2010 - 05/2002
3	Liver Transplantation 09/2010 - 05/2002
2	Immunotherapy 10/2021 - 01/2019
2	Precision Medicine 05/2017 - 01/2015
2	Lasers (Laser) 04/2010 - 10/2008
2	Chemoprevention 07/2005 - 12/2004
1	Metastasectomy 10/2022
1	Hepatectomy 01/2022
1	Castration 01/2017
1	Cystectomy 01/2016